Advanced search
Publication Cover
Breast Cancer: Targets and Therapy Volume 9, 2017 - Issue
Submit an article Journal homepage
161
Views
12
CrossRef citations to date
0
Altmetric
Review

Alternative therapies for metastatic breast cancer: multimodal approach targeting tumor cell heterogeneity

Manpreet Sambi1 Department of Biomedical and Medical Sciences, Queen’s University, Kingston, ON, Canada
,
Sabah Haq1 Department of Biomedical and Medical Sciences, Queen’s University, Kingston, ON, Canada
,
Vanessa Samuel1 Department of Biomedical and Medical Sciences, Queen’s University, Kingston, ON, Canada
,
Bessi Qorri1 Department of Biomedical and Medical Sciences, Queen’s University, Kingston, ON, Canada
,
Fiona Haxho1 Department of Biomedical and Medical Sciences, Queen’s University, Kingston, ON, Canada
,
Kelli Hill1 Department of Biomedical and Medical Sciences, Queen’s University, Kingston, ON, Canada;2 ENCYT Technologies, Inc., Membertou, NS, Canada
,
William Harless2 ENCYT Technologies, Inc., Membertou, NS, CanadaCorrespondence[email protected]
&
Myron R Szewczuk1 Department of Biomedical and Medical Sciences, Queen’s University, Kingston, ON, CanadaCorrespondence[email protected]
 show all
Pages 85-93 | Published online: 28 Feb 2017

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Manpreet Sambi, Vanessa Samuel, Bessi Qorri, Sabah Haq, Sergey V Burov, Elena Markvicheva, William Harless & Myron R Szewczuk. (2020) A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer. Drug Design, Development and Therapy 14, pages 1995-2019.
Read now
Richard E Kast, Nicolas Skuli, Samuel Cos, Georg Karpel-Massler, Yusuke Shiozawa, Ran Goshen & Marc-Eric Halatsch. (2017) The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy. Breast Cancer: Targets and Therapy 9, pages 495-514.
Read now

Articles from other publishers (10)

Sander Bekeschus, Fariba Saadati & Steffen Emmert. (2022) The potential of gas plasma technology for targeting breast cancer. Clinical and Translational Medicine 12:8.
Crossref
Anna-Lena Mueller, Aranka Brockmueller, Niusha Fahimi, Tahere Ghotbi, Sara Hashemi, Sadaf Sadri, Negar Khorshidi, Ajaikumar B. Kunnumakkara & Mehdi Shakibaei. (2022) Bacteria-Mediated Modulatory Strategies for Colorectal Cancer Treatment. Biomedicines 10:4, pages 832.
Crossref
Saeideh Jafarinejad-Farsangi, Mahnaz Sadat Hashemi, Seyede Elmira Yazdi Rouholamini, Sdigheh Gharbi, Zeinab Ansari-Asl, Elham Jafari, Amin Shiralizadeh Dezfuli & Mariam Shahrokhi-Farjah. (2021) Curcumin loaded on graphene nanosheets induced cell death in mammospheres from MCF-7 and primary breast tumor cells. Biomedical Materials 16:4, pages 045040.
Crossref
Paolo Siano, Alexis Johnston, Paula Loman-Cortes, Zaneta Zhin & Juan L. Vivero-Escoto. (2020) Evaluation of Polyhedral Oligomeric Silsesquioxane Porphyrin Derivatives on Photodynamic Therapy. Molecules 25:21, pages 4965.
Crossref
Sambi, DeCarlo, Malardier-Jugroot & Szewczuk. (2019) Next-Generation Multimodality of Nanomedicine Therapy: Size and Structure Dependence of Folic Acid Conjugated Copolymers Actively Target Cancer Cells in Disabling Cell Division and Inducing Apoptosis. Cancers 11:11, pages 1698.
Crossref
Larissa E. Hillebrand & Thomas Reinheckel. (2019) Impact of proteolysis on cancer stem cell functions. Biochimie 166, pages 214-222.
Crossref
Claudia Riccardi, Domenica Musumeci, Marco Trifuoggi, Carlo Irace, Luigi Paduano & Daniela Montesarchio. (2019) Anticancer Ruthenium(III) Complexes and Ru(III)-Containing Nanoformulations: An Update on the Mechanism of Action and Biological Activity. Pharmaceuticals 12:4, pages 146.
Crossref
Manpreet Sambi & Myron R. Szewczuk. 2019. Current Applications for Overcoming Resistance to Targeted Therapies. Current Applications for Overcoming Resistance to Targeted Therapies 1 33 .
Yuanli Huang, Hongtao Wang & Yuanrong Yang. (2018) Annexin A7 is correlated with better clinical outcomes of patients with breast cancer. Journal of Cellular Biochemistry 119:9, pages 7577-7584.
Crossref
Constanze Buhrmann, Parviz Shayan, Ajay Goel & Mehdi Shakibaei. (2017) Resveratrol Regulates Colorectal Cancer Cell Invasion by Modulation of Focal Adhesion Molecules. Nutrients 9:10, pages 1073.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.